Skip to main content
OpenTrials
Completed

NCT Number: NCT06787287

A Study on the Application of Simple and Improved Radial Artery Compression Method After Transradial Coronary Intervention

The objective of this study was to evaluate the specific effect of a simple modified method of thick gauze (9cm*16cm*8mm) combined with a hemostatic device in the prevention of early radial artery occlusion and other related vascular complications after transradial coronary intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

First Hospital of China Medical University

Shenyang, Liaoning, China

About this study

Clinically, coronary intervention through radial artery is a common path for cardiovascular interventional therapy in recent years, and relevant clinical RCT studies and meta-analyses have confirmed that transradial intervention (TRI) has more benefits than transfemoral artery. Including reducing patient pain, easy pressure hemostasis, postoperative patients can not have to stay in bed, fewer vascular complications, reduce patient hospitalization costs and other advantages. However, radial artery occlusion (RAO) and hematoma are the most common postoperative complications of TRA. Although the vast majority of cases are asymptomatic from an ischemia perspective, it rules out ipsilateral TRA for future surgery. In particular, RAO will restrict the use of the radial artery to create an arteriovenous fistula for patients requiring hemodialysis, in addition to the fact that patients at high blood risk may not receive the benefits of the radial artery access in the case of repeat surgery. Therefore, the prevention of postoperative RAO is of fundamental clinical importance. Among the various strategies used to prevent RAO, postoperative arterial compression time and arterial compression level are important factors in changing the occurrence of RAO. In the CRASOC study, which included 3616 patients who were randomly divided into 3 groups, the incidence of RAO was 2.3% when hemostatic compression (10 ml of air) was light and short (1.5 hours). The incidence of RAO was 7.9% when hemostatic compression was lighter (10 ml of air) but longer (4 hours) and 9.4% when stronger pressure was applied (13 ml of air) and longer (4 hours), and the CRASOC trial highlights the effectiveness of combining a minimum pressure strategy with a short compression duration for the prevention of RAO. However, a very short compression duration may increase the rate of rebleeding at the puncture site, resulting in a renewed need for increased hemostatic pressure, which may paradoxically increase the incidence of RAO.

At present, when traditional pressure hemostasis is difficult in clinic or postoperative pressure pain is unbearable, our center often adopts a simple and improved method of thick gauze block (9cm*16cm*8mm) combined with hemostatic device, which can significantly improve the hemostatic effect. However, this method is only in the experience of single-center surgeons and has not been verified by relevant clinical studies. The center intends to conduct this clinical study to systematically evaluate the application effect of this improved compression method in radial artery compression hemostasis after transradial coronary intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Over 18 years old, regardless of gender;
  • Patients undergoing coronary intervention;
  • Patients with a transradial approach;
  • Voluntarily participate and sign informed consent;

Exclusion criteria

  • Intraoperative Allen test was positive for all patients;
  • The intraoperative Barbeau tests were all D grade radial artery patients;
  • Patients with blood or liver diseases;
  • Patients with vascular diseases or malformations in the forearm;
  • Patients with a history of RAO at baseline of the radial artery on the approach;
  • Approach side arteriovenous fistula dialysis patients;
  • Patients with subclavian artery occlusive disease (definite medical history or the difference in systolic blood pressure between the two upper limbs is more than 20mmHg);
  • Patients who have completed coronary intervention (full heparin);
  • Active bleeding at the puncture site before extraction;
  • Systolic blood pressure greater than 180 mm Hg or diastolic blood pressure greater than 110 mm Hg at closure;
  • Pregnant women or patients who are trying to conceive and have family plans;
  • Patients whom the investigator deems inappropriate to participate in the clinical trial;

Treatment and study plan

Modified compression method

Procedure

In the experimental group, an improved compression method was adopted. A thick gauze block of 9cm*16cm*8mm was folded three times and placed at the puncture site of the patient's radial artery, and a spiral radial artery hemostatic device was placed above it. The control group was treated with traditional compression method, and the spiral radial artery hemostat was applied directly at the radial artery puncture

Primary outcomes

  1. Incidence of 24-hours RAO (radial artery occlusion)

    Time frame: Acute radial artery occlusion was evaluated at 24 hours after the percutaneous coronary intervention

    Color Doppler ultrasound was used to determine the incidence of RAO (radial artery occlusion) at 24 hours after the percutaneous coronary intervention in both groups

Secondary outcomes

  1. Occurrence of forearm hematomas

    Time frame: Within 24 hours after the procedure

    Forearm hematomas were recorded and graded using the EASY (Early Discharge After Transradial Stenting of Coronary Arteries) classification system, based on size and clinical presentation.

  2. Postoperative pain within 24 hours

    Time frame: 24 hours after the procedure

    Pain intensity at the puncture site was assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain).

  3. Presence of palm swelling

    Time frame: Within 24 hours after the procedure

    Palm swelling was defined as a circumference increase of more than 0.5 cm compared with baseline, measured at the same palm location using a flexible tape measure.

  4. Occurrence of forearm cyanosis

    Time frame: Within 24 hours after the procedure

    Cyanosis was visually assessed and defined as discoloration (bluish or purple tint) of the forearm skin, indicating impaired circulation.

  5. Presence of finger numbness

    Time frame: Within 24 hours after the procedure

    Numbness was assessed by patient report and physical examination, defined as subjective loss or reduction of sensation in one or more fingers on the puncture side.

  6. Incidence of tension blisters at the puncture site

    Time frame: Within 24 hours after the procedure

    Tension blisters were visually assessed and categorized as mild (small, localized, minimal pain) or severe (large, spreading, or with associated significant pain), based on extent and patient-reported symptoms.

  7. Change in radial artery diameter from baseline

    Time frame: From baseline to 24 hours post-procedure

    Radial artery internal diameter was measured using color Doppler ultrasound at baseline and at 24 hours after the procedure, and the change was calculated to assess vascular response.

Sponsors and collaborators

Lead sponsor

Guozhe Sun

Other

Registry information

Official study title

A Study on the Application of Simple and Improved Radial Artery Compression Method After Transradial Coronary Intervention A Randomized, Controlled Clinical Trial

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Jan 22, 2025
Registry last updated
Oct 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.